JP Morgan Chase’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-154,964
Closed -$8.69M 5411
2016
Q4
$8.69M Buy
154,964
+147,883
+2,088% +$7.54M ﹤0.01% 2023
2016
Q3
$342K Buy
7,081
+1,950
+38% +$90.8K ﹤0.01% 3530
2016
Q2
$214K Buy
5,131
+1,387
+37% +$51.6K ﹤0.01% 3702
2016
Q1
$122K Buy
+3,744
New +$108K ﹤0.01% 3716
2015
Q3
Sell
-6,067
Closed -$211K 4231
2015
Q2
$211K Buy
+6,067
New +$198K ﹤0.01% 3798

Other funds holding VASC

JP Morgan Chase's VASC Position: Q1 2017 in Review

JP Morgan Chase sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 154,964 shares — an estimated $8.69M sold.

JP Morgan Chase first reported a position in VASC in Q2 2015 and held it in 5 quarters. The position peaked at $8.69M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • JP Morgan Chase reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 154,964 Vascular Solutions Inc shares in Q1 2017, an estimated $8.69M.
  • JP Morgan Chase first reported a position in Vascular Solutions Inc in Q2 2015 and held it in 5 quarters.
  • JP Morgan Chase's Vascular Solutions Inc position peaked at $8.69M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.